바이오 탐색대Metsera eyes $289M IPO to fund phase 3 weight loss trial https://www.fiercebiotech.com/biotech/metsera-eyes-289m-ipo-fund-phase-3-weight-loss-trial약 1억 주 x 15-17$ = 1.5-1.7bn (2.2-4조 가량)t.me/PathfinderOfBio/1408TranslateJanuary 27, 2025 2K 2